¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѳ»ºÐºñÇÐȸ SICEM 2023 (The 11th Seoul International Congress of Endocrinology and Metabolism in conjunction with the 42nd Annual Scientific Meeting of Korean Endocrine Society) (1ÀÏÂ÷) : 2023-10-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѳ»ºÐºñÇÐȸ SICEM 2023 (The 11th Seoul International Congress of Endocrinology and Metabolism in conjunction with the 42nd Annual Scientific Meeting of Korean Endocrine Society) (1ÀÏÂ÷) : 2023-10-26
±³À°ÀÏÀÚ : 2023-10-26
±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ¿ùµå

±³À°ÁÖÁ¦ : SICEM 2023 (The 11th Seoul International Congress of Endocrinology and Metabolism in conjunction with the 42nd Annual Scientific Meeting of Korean Endocrine Society) (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : ¹Ú¼öºó
¿¬¶ôó : 02-2038-0072  

À̸ÞÀÏ : endo@endocrinology.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 2Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 350,000¿ø  

ºñ°í ÇöÀåµî·Ï ºñȸ¿ø : Àü¹®ÀÇ 350,000/Àü°øÀÇ175,000¿ø/±âŸ 250,000¿øÇöÀåµî·Ï ȸ¿ø : Àü¹®ÀÇ 250,000/Àü°øÀÇ125,000¿ø/±âŸ 200,000¿ø»çÀüµî·Ï ºñȸ¿ø : Àü¹®ÀÇ 250,000/Àü°øÀÇ125,000¿ø/±âŸ 200,000¿ø»çÀüµî·Ï ȸ¿ø : Àü¹®ÀÇ 200,000/Àü°øÀÇ100,000¿ø/±âŸ 150,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 10¿ù 26ÀÏ Room3 16:30~17:00 Consideration of Quality of Life in Thyroid Cancer Anna M. Sawka(University of Toronto, Canada)

±³À°½Ã°£ 10¿ù 26ÀÏ Room3 17:00~17:30 Economic burden for thyroid cancer patients in Korea Mijin Kim(Pusan National University, Korea)

±³À°½Ã°£ 10¿ù 26ÀÏ Room3 17:30~18:00 Post-RAI health outcome in thyroid diseases Kyeong Jin Kim(Korea University, Korea)

±³À°½Ã°£ 10¿ù 26ÀÏ Room4 16:30~17:00 Senoinflammation as the basis of pathophysiological senescence and its potential intervention Hae Young Chung(Pusan National University, Korea)

±³À°½Ã°£ 10¿ù 26ÀÏ Room4 17:00~17:30 Tumorigenic roles of senescent cells in the cancer microenvironment Akiko Takahashi(Japanese Foundation for Cancer Research, Japan)

±³À°½Ã°£ 10¿ù 26ÀÏ Room4 17:30~18:00 Clinically available medications that possess anti-senescence efficacies Jeong-hyun Park(Inje University, Korea)

±³À°½Ã°£ 10¿ù 26ÀÏ Room5 16:30~16:50 Hypothalamic cytokines in metabolic syndrome Minsoo Kim(KIST, Korea)

±³À°½Ã°£ 10¿ù 26ÀÏ Room5 16:50~17:10 Role of GPER in AgRP neurons on energy balance Obin Kwon(Seoul National University, Korea)

±³À°½Ã°£ 10¿ù 26ÀÏ Room5 17:10~17:30 Hypothalamic obesity: subtyping and the role of GLP-1 receptor agnonist Seung Shin Park(Seoul National University, Korea)

Åä·Ð 10¿ù 26ÀÏ Room5 17:30~18:00 Åä·Ð ()

±³À°½Ã°£ 10¿ù 26ÀÏ Room3 19:00~19:30 Gemigliptin + dapagliflozin: optimal combination for holistic diabetes treatment Dughyun Choi(Soonchunhyang University, Korea)

±³À°½Ã°£ 10¿ù 26ÀÏ Room3 19:30~20:00 Optimal diabetes management with evidence-based Soree Ryang(Pusan National University, Korea)

±³À°½Ã°£ 10¿ù 26ÀÏ Room4 19:00~19:30 Early intervention of type 2 diabetic patient considering cardio-renal-metabolic system Jae-seung Yun(The Catholic University of Korea, Korea)

±³À°½Ã°£ 10¿ù 26ÀÏ Room4 19:30~20:00 New paradigm: benefits of combination treatment of SGLT2 inhibitor & DPP-4 inhibitor Ju Hee Lee(Chungnam National Universtiy, Korea)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ã¾Æ°¡´Â °­¿øÁöȸ ¼¼¹Ì³ª : 2023-10-27
´ÙÀ½±Û 2023³â Á¦16ȸ ³»°úÀü°øÀÇ Çٽɿª·® ¿¬¼ö°­Á (1ÀÏÂ÷) : 2023-10-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,466 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 2,018 2018-07-28
1411 | 1412 | 1413 | 1414 | 1415
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷